Annovis Bio gets NYSE non-compliance notice; 30-day average market cap $48.4M, equity deficit $(4.3)M

Annovis Bio, Inc.

• NYSE notice dated Oct 29, 2026 cites Section 802.01B: 30 trading-day average market cap below $50M ($48.4M as of Oct 28) with stockholders' equity under $50M.
• Last reported stockholders' deficit was approximately $(4.3) million as of June 30, 2026, per the notice.
• Company will submit a cure plan within 45 days; NYSE has 45 days to accept, with a 9-month cure period from notice receipt.
• Ticker ANVS keeps trading but gains a ".BC" designation until compliance is regained; NYSE may act fast if shares trade below $0.10.
• Company says the notice does not affect operations, SEC reporting, or cause default under material debt agreements.